Cancer UrologyCancer UrologyОнкоурология1726-97761996-1812Publishing House ABV Press17410.17650/1726-9776-2013-9-1-43-49PROSTATE CANCERРАК ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫROLE OF THE KALLIKREIN-KININ RECEPTOR SYSTEM IN PROSTATIC PROLIFERATIVE PROCESSESРОЛЬ РЕЦЕПТОРНОГО АППАРАТА КАЛЛИКРЕИН-КИНИНОВОЙ СИСТЕМЫ В ПРОЛИФЕРАТИВНЫХ ПРОЦЕССАХ ПРЕДСТАТЕЛЬНОЙ ЖЕЛЕЗЫChibichyanM. B.ЧибичянМ. Б.
Russian Federation
dept_kogan@mail.ruMatsionisA. E.МационисА. Э.
Russian Federation
dept_kogan@mail.ruPovilaititeP. E.ПовилайтитеП. Э.
Russian Federation
dept_kogan@mail.ruKoganM. I.КоганМ. И.
Russian Federation
dept_kogan@mail.ruResearch Institute of Urology and Nephrology, Rostov State Medical UniversityНИИ урологии и нефрологии РостовскогоГМУRostov Postmortem Bureau, Rostov-on-DonРостовское патологоанатомическое бюро, Ростов-на-Дону300320139143493007201430072014https://oncourology.abvpress.ru/oncur/article/view/174

In prostatic hyperplasia (PH) and prostate cancer (PC), changes in major cell functions are manifested by impairments in the expression levels of genes and their products, in transmissions, etc. The regulatory components of the renin-angiotensin and kallikrein-kinin systems are known to play a vital role in ensuring the homeostasis of tissue, including that of prostatic tissue. It is promising to elucidate the specific features of these processes in the diagnosis of PC. Polyfocal prostate puncture biopsy specimens were examined in 15 males with PC and 15 with benign PH (BPH). Immunohistochemical reactions were made in an automatic robotic apparatus. B1 expression was ascertained to be fully absent in patients with BPH. Malignant acini and prostatic intraepithelial neoplastic foci showed a specific reaction with anti-B1 antibodies in the glandular epithelium. B2 expression was seen in the stroma in both BPH and PC irrespective of their stage and total Gleason scores. The findings of the pattern of B1 expression suggest that it may be used as a marker for PC.

prostate cancerbenign prostatic hyperplasiaprostate-specific antigenrenin-angiotensin and kallikrein-kinin systemsreceptor expressionрак предстательной железыдоброкачественная гиперплазия предстательной железыпростатспецифический антигенренин-ангиотензиновая и калликреин-кининовая системыэкспрессия рецепторов1. Александров В.П., Карелин М.И. Рак предстательной железы. СПб.: Издательский дом СПбМАПО, 2004. 148 с.Александров В.П., Карелин М.И. Рак предстательной железы. СПб.: Издательский дом СПбМАПО, 2004. 148 с.2. Злокачественные новообразования в России в 2008 г. (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГУ «МНИОИ им. П.А. Герцена». 2010. 256 с.Злокачественные новообразования в России в 2008 г. (заболеваемость и смертность). Под ред. В.И. Чиссова, В.В. Старинского, Г.В. Петровой. М.: ФГУ «МНИОИ им. П.А. Герцена». 2010. 256 с.3. Wright J.K., Botha J.H., Naidoo S. Influence of the kallikrein-kinin system on prostate and breast tumour angiogenesis. Tumour Biol 2008;29(2):130–6.Wright J.K., Botha J.H., Naidoo S. Influence of the kallikrein-kinin system on prostate and breast tumour angiogenesis. Tumour Biol 2008;29(2):130–6.4. Puddefoot J.R., Udeozo U.K., Barker S., Vinson G.P. The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion. Endocr Relat Cancer 2006;13:895–903.Puddefoot J.R., Udeozo U.K., Barker S., Vinson G.P. The role of angiotensin II in the regulation of breast cancer cell adhesion and invasion. Endocr Relat Cancer 2006;13:895–903.5. Costa-Neto C.M., Dillenburg-Pilla P., Heinrich T.A. et al. Participation of kallikrein-kinin system in different pathologies. Int Immunopharmacol 2008;8(2):135–42.Costa-Neto C.M., Dillenburg-Pilla P., Heinrich T.A. et al. Participation of kallikrein-kinin system in different pathologies. Int Immunopharmacol 2008;8(2):135–42.6. Lyons-Darden T., Daaka Y. Requirement for G proteins in insulin-like growth factor-I-induced growth of prostate cells. J Mol Endocrinol 2004;33(1):165–73.Lyons-Darden T., Daaka Y. Requirement for G proteins in insulin-like growth factor-I-induced growth of prostate cells. J Mol Endocrinol 2004;33(1):165–73.7. Baker K.M., Kumar R. Intracellular angiotensin II induces cell proliferation independent of AT1 receptor. Am J Physiol Cell Physiol 2006;291(5):995–1001.Baker K.M., Kumar R. Intracellular angiotensin II induces cell proliferation independent of AT1 receptor. Am J Physiol Cell Physiol 2006;291(5):995–1001.8. Cook J.L., Mills S.J., Naquin R.T. et al. Cleavage of the angiotensin AT1 receptor and nuclear accumulation of the cytoplasmic carboxy-terminal fragment. Am J Physiol Cell Physiol 2007;292:1313–22.Cook J.L., Mills S.J., Naquin R.T. et al. Cleavage of the angiotensin AT1 receptor and nuclear accumulation of the cytoplasmic carboxy-terminal fragment. Am J Physiol Cell Physiol 2007;292:1313–22.9. Wolf G., Wenzel U., Burns K.D. et al. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.Kidney Int2002;61:1986–95.Wolf G., Wenzel U., Burns K.D. et al. Angiotensin II activates nuclear transcription factor-kappaB through AT1 and AT2 receptors.Kidney Int2002;61:1986–95.10. Jagannathan R., Kaveti S., Desnoyer R.W. et al. AT1 receptor induced alterations in histone H2A reveal novel insights into GPCR control of chromatin remodeling. PLoS One 2010;5(9):12552–6.Jagannathan R., Kaveti S., Desnoyer R.W. et al. AT1 receptor induced alterations in histone H2A reveal novel insights into GPCR control of chromatin remodeling. PLoS One 2010;5(9):12552–6.11. Pendergrass K.D., Gwathmey T.M., Michalek R.D. et al. The Angiotensin II – AT1 Receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 2009;384(2):149–14.Pendergrass K.D., Gwathmey T.M., Michalek R.D. et al. The Angiotensin II – AT1 Receptor stimulates reactive oxygen species within the cell nucleus. Biochem Biophys Res Commun 2009;384(2):149–14.12. Tadevosyan A., Maguy A., Villeneuve L.R. et al. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem2010;285(29):22338–49.Tadevosyan A., Maguy A., Villeneuve L.R. et al. Nuclear-delimited angiotensin receptor-mediated signaling regulates cardiomyocyte gene expression. J Biol Chem2010;285(29):22338–49.13. Ignjacev-Lazich I., Kintsurashvili E., Conrado J. et al.Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol 2005;289:1814–20.Ignjacev-Lazich I., Kintsurashvili E., Conrado J. et al.Angiotensin-converting enzyme regulates bradykinin receptor gene expression. Am J Physiol 2005;289:1814–20.14. Leeb-Lundberg L.M., Marceau F., Muller-Esterl W. et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.Pharmacol Rev 2005;57:27–77.Leeb-Lundberg L.M., Marceau F., Muller-Esterl W. et al. International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences.Pharmacol Rev 2005;57:27–77.15. Zhang W., Bhola N., Kalyankrishna S. et al. Kinin B2 receptor mediates induction of cyclooxygenase-2 and Isoverexpressed in head and neck squamous cell carcinomas. Mol Cancer Res 2008;6:1946–56.Zhang W., Bhola N., Kalyankrishna S. et al. Kinin B2 receptor mediates induction of cyclooxygenase-2 and Isoverexpressed in head and neck squamous cell carcinomas. Mol Cancer Res 2008;6:1946–56.16. Taub J.S., Guo R., Leeb-Lundberg L.M.F. et al. Bradykininreceptor subtype 1 expression and function in prostate cancer. Cancer Res 2003;63:2037–41.Taub J.S., Guo R., Leeb-Lundberg L.M.F. et al. Bradykininreceptor subtype 1 expression and function in prostate cancer. Cancer Res 2003;63:2037–41.17. Bernier S.G., Haldar S., Michel T. Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem 2000; 275:30707–15.Bernier S.G., Haldar S., Michel T. Bradykinin-regulated interactions of the mitogen-activated protein kinase pathway with the endothelial nitric-oxide synthase. J Biol Chem 2000; 275:30707–15.18. Lin J., Freeman M.R. Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells. Prostate 2003;54:1–7.Lin J., Freeman M.R. Transactivation of ErbB1 and ErbB2 receptors by angiotensin II in normal human prostate stromal cells. Prostate 2003;54:1–7.19. Re R.N. Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol 2007;293:295–6.Re R.N. Intracellular renin-angiotensin system: the tip of the intracrine physiology iceberg. Am J Physiol 2007;293:295–6.